Cytek Biosciences Reports Second Quarter 2026 Financial Results

Go back to Cytek Biosciences Reports Second Quarter 2026 Financial Results
(NASDAQ: CTKB) Delayed: 4.67 --0 (-0%)
Previous Close $4.67    52 Week High
Open $4.67    52 Week Low
Day High $4.67    P/E N/A 
Day Low $4.67    EPS
Volume 21